Molecular Inhibitor of QSOX1 Suppresses Tumor GrowthIn Vivo
- 1 January 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 19 (1) , 112-122
Abstract
Quiescin sulfhydryl oxidase 1 (QSOX1) is an enzyme overexpressed by many different tumor types. QSOX1 catalyzes the formation of disulfide bonds in proteins. Because short hairpin knockdowns (KD) of QSOX1 have been shown to suppress tumor growth and invasion in vitro and in vivo, we hypothesized that chemical compounds inhibiting QSOX1 enzymatic activity would also suppress tumor growth, invasion, and metastasis. High throughput screening using a QSOX1-based enzymatic assay revealed multiple potential QSOX1 inhibitors. One of the inhibitors, known as “SBI-183,” suppresses tumor cell growth in a Matrigel-based spheroid assay and inhibits invasion in a modified Boyden chamber, but does not affect viability of nonmalignant cells. Oral administration of SBI-183 inhibits tumor growth in 2 independent human xenograft mouse models of renal cell carcinoma. We conclude that SBI-183 warrants further exploration as a useful tool for understanding QSOX1 biology and as a potential novel anticancer agent in tumors that overexpress QSOX1.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (CA78383-20)
- HHS | National Institutes of Health (CA224917)
- U.S. Department of War (W81XWH-17-1-0546)
- Gloria A. and Thomas J. Dutson Jr. Endowment
- HHS | National Institutes of Health (CA201226)
- HHS | National Institutes of Health (CA201226)
- HHS | National Institutes of Health (CA201226)
This publication has 46 references indexed in Scilit:
- Elevated Transcription of the Gene QSOX1 Encoding Quiescin Q6 Sulfhydryl Oxidase 1 in Breast CancerPLOS ONE, 2013
- On the origins of drug polypharmacologyMedChemComm, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Inhibition of Prohormone Convertases PC1/3 and PC2 by 2,5-Dideoxystreptamine DerivativesMolecular Pharmacology, 2012
- Examinations of tRNA Range of Motion Using Simulations of Cryo-EM Microscopy and X-Ray DataJournal of Biophysics, 2011
- QSOX contains a pseudo‐dimer of functional and degenerate sulfhydryl oxidase domainsFEBS Letters, 2010
- Novel Method for Generating Structure-Based Pharmacophores Using Energetic AnalysisJournal of Chemical Information and Modeling, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Human Quiescin-Sulfhydryl Oxidase, QSOX1: Probing Internal Redox Steps by MutagenesisBiochemistry, 2008
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003